Transparency Initiative
At Fresenius Kabi we care for the life of patients worldwide. To fulfill our commitment to benefit critically and chronically ill patients, collaborating with Healthcare Professionals, hospitals and patient organisations is essential. These partnerships are not only required to develop products that best meet clinical needs. Healthcare Professionals are provided with the necessary expertise and education to be able to safely and effectively use our drugs and medical devices. In supporting medical research and education Fresenius Kabi contributes to patient safety and increased access to new technologies and services.
We expect transparency, accountability and high ethical standards from ourselves – and our stakeholders expect the same from us. Their trust is rewarded by acting with utmost integrity and responsibility. We believe that transparency is key to safeguard the integrity of these partnerships to the public and remain trusted.
Being member of various industry associations in the countries we are operating in, we have committed ourselves to disclose certain value transfers to Healthcare Professionals, Healthcare Organizations and selected patient care organizations in these countries.
In each such interaction, we respect the obligation of Healthcare Professionals to make independent treatment decisions.
Transparency Initiative
Transparency Initiative Fresenius Kabi UK Ltd At Fresenius Kabi we care for the life of patients worldwide. To fulfil our commitment to benefit critically and chronically ill patients, collaborating with physicians, hospitals and patient organisations is essential. These partnerships are not only required to develop products that best meet clinical needs. Healthcare professionals are provided with necessary expertise and education to be able to safely and effectively use our drugs and medical devices. In supporting medical research and education Fresenius Kabi contributes to patient safety and increased access to new technologies and services.
To read the full report click here
Fresenius Kabi Limited and Calea UK Limited 2022 Patient Organisations Disclosure Report
We believe that being transparent about our support for patient groups helps to build trust with our stakeholders. During 2022 we did not provide support to patient organisations.
To review the full 2022 Patient Organisations Disclosure Report click here
To read the 2021 Patient Organisations Disclosure Report click here
To read the 2020 Patient Organisations Disclosure Report click here
Fresenius Kabi Limited and Calea UK Limited Methodological Notes for Reporting 2022
As a member of EFPIA and in accordance with ABPI requirements, Fresenius Kabi Limited and Calea UK Limited ensure that the nature and scope of any transfers of value with healthcare professionals and healthcare organisations are clear and transparent.
To read the full 2022 report click here
To read the 2021 Methodological Notes for Reporting click here
To read the 2020 Methodological Notes for Reporting click here
Methodological note for 2020 Healthcare professionals, healthcare organisations transfers of value disclosure. Disaggregated disclosure can be found on Disclosure Search (disclosureuk.org.uk).
Fresenius Kabi Engagement Policy 2020
To read the full Fresenius Kabi Enagagement Policy Implementation Statement 2020 please click here
HCP / HCO Disclosure Values 2019
To read the full Fresenius Kabi HCP/HCO Disclosure Values Report click here
We welcome any questions or remarks at transparency@fresenius-kabi.com.